Chief Executive Officer of ProKidney
Dr. Bertram brings over 35 years of medicine development leadership, funding and expertise with demonstrated innovations in small molecular and cellular therapeutics. Tim is an experienced Chief Executive Officer with a demonstrated history of working in the biotechnology industry. Currently, CEO of ProKidney, a multi-national privately owned clinical-stage cellular therapeutics company focusing on treatment of chronic renal disease. Serves as Director of NexImmune a cell-based immuno-oncology biotechnology company with committee leadership. Previously, Tim served as CEO of RegenMed Therapeutics, after serving as President of Research and Development to bring four cell-based therapeutic products from discovery through Phase II clinical development.
Dr. Bertram is highly skilled in Research and Development (R&D), Life Sciences, Regenerative Medicine, Clinical Development, and Molecular Biology. He possesses strong business development experience and expertise in raising private and public funds. Dr. Bertram was a senior executive at Pfizer, SmithKline Beecham Pharmaceuticals, and Procter & Gamble Corporate Research where his career focused on taking molecular entities from research through clinical development and registration. These development efforts lead to the commercialization of eight medical products that are changing and improving lives around the world. Tim started his professional career on faculty at the University of Illinois and as a visiting scientist at the National Institutes of Health.
Tim and his wife Julie, a former nurse, have three children, four grandchildren and make their home in Statesville, North Carolina.